Immucell Corp (ICCC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Sales | 2,154 | 3,015 | 2,881 | 3,133 | 2,005 |
| Cost of Goods | 1,203 | 1,528 | 1,521 | 1,920 | 1,069 |
| Gross Profit | 951 | 1,487 | 1,360 | 1,212 | 936 |
| Operating Expenses | 1,303 | 2,208 | 2,059 | 2,546 | 1,487 |
| Operating Income | -149 | -193 | -178 | -413 | -482 |
| Other Income | -107 | -103 | -92 | -80 | -49 |
| Pre-tax Income | -256 | -297 | -270 | -493 | -532 |
| Income Tax | -6 | 502 | -49 | -298 | -192 |
| Net Income Continuous | -250 | -798 | -221 | -195 | -339 |
| Net Income | $-250 | $-798 | $-221 | $-195 | $-339 |
| EPS Basic Total Ops | -0.05 | -0.15 | -0.04 | -0.03 | -0.07 |
| EPS Basic Continuous Ops | -0.05 | -0.15 | -0.04 | -0.04 | -0.07 |
| EPS Diluted Total Ops | -0.05 | -0.15 | -0.04 | -0.03 | -0.07 |
| EPS Diluted Continuous Ops | -0.05 | -0.15 | -0.04 | -0.04 | -0.07 |
| EBITDA(a) | $238 | $96 | $111 | $-150 | $-272 |